1. S2E9 - Cannabis + Hope - The Adam Dunn Show

    02:01:02

    from The Adam Dunn Show / Added

    667 Plays / / 3 Comments

    Adam, Mitch, Ryan & Murphy speak with Joel LeLeu and Ashley Bemus about their son Noah, their decision to treat his tumor with cannabis, and the hardships they face seeking to treat their child without chemotherapy. They're joined by Dave from Elite Cannabis, who gifts the family a treatment of cancer-killing high CBD cannabis oil.

    + More details
    • Questions & Answers 189

      01:45:34

      from Official Robert Morse / Added

      Questions & Answers 189 - Flower Essences - Role of nutrition - Remember the four stages to wellville - Skin Washes - Anxiety Attacks - Headaches - Sweating and Saunas - Gallbladder - Career path - Belly fat and hypothyroidism - Pituitary Tumor Disclaimer The information given by Robert Morse in these videos are strictly for education purposes only. They do not involve the diagnosing, treatment or prescribing of remedies for the treatment of diseases. Recommendations made in these recordings are not considered consultations or recommended individual protocols. Individual consultations and protocols through Dr. Morse are given by appointment only via contact through his clinic.

      + More details
      • Gebärdensprache Gesundheit im Gespräch - Diagnose Brustkrebs

        01:34:08

        from clipmedia Film / Added

        235 Plays / / 0 Comments

        Brustkrebs ist die häufigste bösartige Neubildung bei Frauen. Schätzungsweise 48.000 Frauen erkranken jährlich neu an dieser Krebsart. Auch zunehmend jüngere Frauen sind betroffen. Die Heilungschancen sind gut, wenn der Tumor rechtzeitig erkannt und behandelt wird. Aus diesem Grund hat der Gesetzgeber ein bundesweites organisiertes Screeningprogramm aufbauen lassen. Danach stehen alle zwei Jahre allen Frauen im Alter zwischen 50 und 69 Jahren die Teilnahme an dieser Früherkennungsuntersuchung zur Verfügung. Längst gibt es nationale Leitlinien zur Diagnostik, Therapie und Nachsorge von Brustkrebs. Am aller wichtigsten ist es aber, dass Frauen selbst gut und umfassend informiert sind. Dazu gehören auch die regelmäßige Beobachtung des eigenen Körpers und das Wissen über die Möglichkeiten vor Ort. Kassel hat allein zwei zertifizierte Brustzentren, die mit den niedergelassenen Gynäkologen, Hausärzten, mit Selbsthilfegruppen und weiteren Therapeuten eng zusammenarbeiten. Beide Leiter der Brustzentren stellen sich an diesen Abend vor, Dr. Bettina Conrad, Elisabeth-Krankenhaus Kassel und Prof. Dr. Thomas Dimpfl, Frauenklinik Klinikum Kassel. Außerdem stellen sich für Fragen und Antworten der Gynäkologe Dr. Hans Urbanczyk, Hiltraud Ammann, Frauenselbsthilfe nach Krebs und Regina Möller, mamazone - Frauen und Forschung gegen Brustkrebs e. V. in der Podiumsdiskussion zur Verfügung. Vortrag Prof. Dr. Thomas Dimpfl ab 5.49 Minute Vortrag Dr. Bettina Conrad ab 23.41 Minute Fragerunde Zuschauerinnen ab 1.01.00 Minute

        + More details
        • Cancer is Not a Cell It's a Fungus (Candida), Preventive care is Deathcare in Sheep's Clothing

          01:20:12

          from zEDIFICATION / Added

          17 Plays / / 0 Comments

          Vitamin B17 http://www.b17.com.au/

          + More details
          • Qué son y cómo se tratan los Tumores Huérfanos e Infrecuentes del SNC

            01:19:34

            from GEPAC / Added

            74 Plays / / 0 Comments

            Título: "Qué son y cómo se tratan los tumores huérfanos del Sistema Nervioso Central" Ponente: Dr. Ramón de las Peñas Día y hora: lunes 27 de enero de 2012 18.00 a 20.00 Centro: Hospital Provincial de Castellón

            + More details
            • Special lecture: Manuel Serrano, PhD - Tumor suppressor genes in cancer and beyond

              01:09:28

              from CIC bioGUNE Bilbao / Added

              84 Plays / / 0 Comments

              The seminar has three parts, each of them with unpublished data. First, I will review the current knowledge about cellular senescence and its role in tumor suppression. I will present our most recent data on the interplay between inflammation and senescence, and on the role of senescence during embryonic development. In the second part, I will present our most recent data on a new preclinical approach against lung cancer targeting the Notch pathway. This will include state-of-the-art in vivo imaging in mice. Finally, I will present our new data on the role of cell cycle regulators during the process of reprogramming of differentiated cells into induced pluripotent stem cells (iPSCs).

              + More details
              • Danny Host Benefit

                01:00:00

                from AC Variety Productions / Added

                55 Plays / / 0 Comments

                Danny Host Benefit at Arbor Park Middle School.

                + More details
                • Tumor proliferation: basic concepts and therapeutic possibilities

                  59:38

                  from Maastro Clinic / Added

                  109 Plays / / 0 Comments

                  Prof. Adrian Begg presented a teaching lecture on Tumor Proliferation invited by Prof. Philippe Lambin. June 2011 MAASTRO Clinic

                  + More details
                  • The circulating tumor cell chip

                    58:46

                    from ISR at UMD / Added

                    361 Plays / / 0 Comments

                    Mehmet Toner Massachusetts General Hospital, Harvard Medical School Harvard-MIT Division of Health Sciences & Technology Abstract Viable tumor-derived circulating tumor cells (CTCs) have been identified in peripheral blood from cancer patients and are probably the origin of intractable metastatic disease. The reliable isolation of CTCs using the microfluidic chip in metastatic cancer offers the possibility of monitoring patient response and changes in tumor genotypes during the course of treatment. However, the ability to isolate CTCs as a potential alternative to invasive biopsies as a source of tumor tissue for detection, characterization and monitoring of cancer patients have proven to be difficult due to the exceedingly low frequency of CTCs in circulation. We previously demonstrated the effectiveness of a microfluidic device, the CTC-Chip, in capturing rare CTCs using antibody-coated micro-posts under laminar flow conditions. More recently, we developed a second-generation chip based on high throughput microfluidic mixing approach, the herringbone-chip, or ‘HB-chip’, which provides an enhanced platform for CTC isolation. The HB-chip design applies passive mixing of blood cells through the generation of micro-vortices to dramatically increase the number of interactions between target CTCs and the antibody-coated chip surface. We applied the microfluidic platforms to blood samples obtained from metastatic lung, prostate, breast, colon, and pancreatic cancer patients. These studies with patient blood showed very high sensitivity and specificity of the microchip. We also tested the microchip in a cohort of patients with metastatic cancer undergoing systemic treatment and showed the temporal changes in CTC numbers correlated well with the clinical course of disease as measured by standard radiographic methods. To further show the utility of the CTC-chip, we isolated CTCs from patients with metastatic non-small-cell-lung cancer and identified the expected EGFR activating mutation in CTCs. We also detected the T790M mutation, which confers drug resistance, in CTCs collected from patients with EGFR mutations who had received tyrosine kinase inhibitors. More recently, we applied microchip to isolate CTCs from blood specimens of patients with either metastatic or localized prostate cancer. Remarkably, the low shear design of the HB-chip revealed micro-clusters of CTCs in a subset of patient samples. Microscopic CTC aggregates may contribute to the hematogenous dissemination of cancer. Currently, the work is focused on dissemination of the technology to multiple clinical centers as well as the development of novel tools for high sensitivity detection of CTCs for early detection of cancer.

                    + More details
                    • Gliomas Lunch and Learn

                      57:43

                      from Mike Doel / Added

                      52 Plays / / 0 Comments

                      Given at Neo Columbus on Friday, May 16, 2014. This is a Lunch and Learn by me (Mike Doel) about my experience of being diagnosed with a glioma and then having it removed.

                      + More details

                      What are Tags?

                      Tags

                      Tags are keywords that describe videos. For example, a video of your Hawaiian vacation might be tagged with "Hawaii," "beach," "surfing," and "sunburn."